Improving Anticancer Drug Selection and Prioritization via Neural Learning to Rank-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improving Anticancer Drug Selection and Prioritization via Neural Learning to Rank

Published:2024-05-13 Issue:10 Volume:64 Page:4071-4088
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Dey Vishal¹,Ning Xia¹²³^ORCID

Affiliation:

1. Department of Computer Science and Engineering, The Ohio State University, Columbus, Ohio 43210, United States

2. Biomedical Informatics, The Ohio State University, Columbus, Ohio 43210, United States

3. Translational Data Analytics Institute, The Ohio State University, Columbus, Ohio 43210, United States

Funder

National Science Foundation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.3c01060

Reference62 articles.

1. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening

2. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

3. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

4. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

5. High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network Medicine: A Potential Approach for Virtual Drug Screening;Pharmaceuticals;2024-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP